Ambio Life Sciences on Instagram: "At the 343 Fund Fireside Chat in Austin, Ambio Co-Founder Trevor Millar spoke candidly about ibogaine’s long-standing Schedule I classification, and why it no longer reflects what clinicians and patients are seeing in real time. Schedule I substances are defined by having: • no currently accepted medical use • high potential for abuse Yet ibogaine is shown to be anti-addictive, profoundly non-recreational, and increasingly studied for its impact on traumatic br